You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FL(Follicular Lymphoma)

Showing 1 - 25 of 6,170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lenalidomide combined with G-CHOP (LO CHOP)
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Obinutuzumab-based Therapy for Previously Untreated FL

Recruiting
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023

Follicular Lymphoma (FL) Trial (biological, drug, other)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Tisagenlecleucel
  • +4 more
  • (no location specified)
May 24, 2023

Obinutuzumab in Combination With Lenalidomide in Relapsed or

Recruiting
  • Follicular Lymphoma
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital ,Chinese Aca
    Apr 27, 2023

    Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

    Completed
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Determination of COVID-19 vacciantion efficacy
    • Rouen, France
      Centre Henri Becquerel
    Dec 22, 2022

    Follicular Lymphoma ( FL), Marginal Zone Lymphoma (MZL) Trial (parsaclisib, rituximab, obinutuzumab)

    Withdrawn
    • Follicular Lymphoma ( FL)
    • Marginal Zone Lymphoma (MZL)
    • (no location specified)
    Jul 14, 2022

    Non Hodgkin Lymphoma, Follicular Lymphoma, Relapsed Follicular Lymphoma Trial in Ostrava-, Oslo (Betalutin)

    Completed
    • Non Hodgkin Lymphoma
    • +2 more
    • Ostrava-, Porubá, Czechia
    • +1 more
    Sep 30, 2022

    Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)

    Recruiting
    • Follicular Lymphoma (FL)
    • Noblesville, Indiana
      Investigative Clinical Research of Indiana
    Oct 18, 2023

    Follicular Lymphoma (FL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

    Recruiting
    • Follicular Lymphoma (FL)
    • Westbury, New York
      Clinical Research Alliance Inc
    Oct 13, 2023

    Follicular Lymphoma, Relapsed and Refractory Follicular Lymphoma Trial in Guangzhou (Orelabrutinib and Rituximab, Orelabrutinib)

    Recruiting
    • Follicular Lymphoma
    • Relapsed and Refractory Follicular Lymphoma
    • Guangzhou, Guangdong, China
    • +2 more
    Mar 23, 2022

    Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)

    Not yet recruiting
    • Follicular Lymphoma
    • Biospecimen Collection
    • +7 more
    • Duarte, California
    • +1 more
    Oct 27, 2023

    Revlimid® Capsules General Drug Use-results Surveillance

    Recruiting
    • Lymphoma Nonhodgkin
      • Japan, Japan
        Local Institution
      Jun 22, 2022

      Relapsed or Refractory (R/R) Follicular Lymphoma (FL), DLBCL (DLBCL) Trial (Odronextamab)

      Available
      • Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
      • Diffuse Large B-Cell Lymphoma (DLBCL)
      • (no location specified)
      Nov 8, 2022

      DLBCL, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in New Haven, Worcester, Dallas (ABBV-319)

      Not yet recruiting
      • Diffuse Large B-Cell Lymphoma
      • +2 more
      • New Haven, Connecticut
      • +2 more
      Aug 22, 2022

      Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

      Not yet recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • +5 more
      • Routine care as per site standard.
      • (no location specified)
      Sep 15, 2023

      DLBCL, MCL, and FL Patients Undergoing CAR Therapy

      Not yet recruiting
      • Follicular Lymphoma
      • +2 more
      • ClonoSEQ
      • Palo Alto, California
        Stanford Cancer Center
      Apr 19, 2022

      Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Brisbane, Clayton, Heidelberg (Durvalumab, Radiotherapy,

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • Follicular Lymphoma
      • Brisbane, Queensland, Australia
      • +2 more
      Feb 14, 2022

      Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing

      Recruiting
      • Relapsed or Refractory B-cell Lymphoma
      • +6 more
      • Beijing, China
        Beijing Cancer Hospital
      Feb 6, 2023

      Diffuse Large B-cell Lymphoma(DLBCL), Mantle Cell Lymphoma (MCL), Follicular Lymphoma (FL) Trial in Worldwide (AMG 562)

      Completed
      • Diffuse Large B-cell Lymphoma(DLBCL)
      • +2 more
      • AMG 562
      • Duarte, California
      • +11 more
      Feb 22, 2022

      Marginal Zone Lymphoma, Follicular Lymphoma, DLBCL Trial in China (Zanubrutinib, Rituximab)

      Completed
      Has Results
      • Marginal Zone Lymphoma
      • +2 more
      • Harbin, Heilongjiang, China
      • +3 more
      Oct 26, 2021

      Follicular Lymphoma Trial in Germany (Copanlisib, Obinutuzumab)

      Recruiting
      • Follicular Lymphoma
      • München, Bavaria, Germany
      • +39 more
      May 19, 2022

      Non-Hodgkin's Lymphoma Trial in Australia, Italy, United States (Obinutuzumab, Rituximab, Polatuzumab Vedotin)

      Completed
      • Non-Hodgkin's Lymphoma
      • Tucson, Arizona
      • +22 more
      Aug 5, 2022

      Follicular Lymphoma and Marginal Zone Lymphoma Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL62 Injection,

      Recruiting
      • Follicular Lymphoma and Marginal Zone Lymphoma
      • Recombinant Humanized Monoclonal Antibody MIL62 Injection
      • Lenalidomide
      • Beijing, China
        Chinese Academy of Medical Sciences and Peking Union Medical Col
      Jun 15, 2021

      Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States

      Recruiting
      • Relapsed/Refractory B-cell Lymphomas
      • +11 more
      • CLBR001 and SWI019
      • Duarte, California
      • +7 more
      Jul 26, 2022

      Lymphoma, Follicular Trial in China (Abexinostat)

      Recruiting
      • Lymphoma, Follicular
      • Beijing, China
      • +25 more
      Mar 3, 2022